Neuro-Oncology Reviews

Volume 25 Number 1
15 January 2023

Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 1, 15 January

Kunikowska J, Morgenstern A, Pełka K, Bruchertseifer F, Królicki L.
Targeted alpha therapy for glioblastoma.
Front Med (Lausanne). 2022 Dec 16, 2022;9:1085245
. doi: 10.3389/fmed.2022.1085245. PMID: 36590948. Review.

Mohanty C, Shandilya K, Deopujari CE, Gupta G, Karmarkar V, Jaggi S.
Cervicomedullary glioblastoma: A report of two cases with review of literature.
Surg Neurol Int. 2022 Dec 16, 2022;13:579
. doi: 10.25259/SNI_581_2022. PMID: 36600754. Case report, Review.

Muthukumar S, Darden J, Crowley J, Witcher M, Kiser J.
A Comparison of PET Tracers in Recurrent High-Grade Gliomas: A Systematic Review.
Int J Mol Sci. 2022 Dec 27, 2023;24(1):408
. doi: 10.3390/ijms24010408. PMID: 36613852. Review.

Raghu ALB, Chen JA, Valdes PA, Essayed W, Claus E, Arnaout O, Smith TR, Chiocca EA, Peruzzi PP, Bernstock JD.
Cerebellar High-Grade Glioma: A Translationally Oriented Review of the Literature.
Cancers (Basel). 2022 Dec 28, 2023;15(1):174
. doi: 10.3390/cancers15010174. PMID: 36612169. Review.

Chen K, Andrade-Barazarte H, Liang W, Zhu Q, Guo H, Li Y, Li H, Qian R.
Post-traumatic brain injury glioma: Characteristics, report of 2 cases report and literature review.
Medicine (Baltimore). 2022 Dec 30, 2022;101(52):e32477
. doi: 10.1097/MD.0000000000032477. PMID: 36596004. Case report, Review.

Goff KM, Zheng C, Alonso-Basanta M.
Proton radiotherapy for glioma and glioblastoma.
Chin Clin Oncol. 2022 Dec 31, 2022;11(6):46
. doi: 10.21037/cco-22-92. PMID: 36632979. Review.

Laurenge A, Huillard E, Bielle F, Idbaih A.
Cell of Origin of Brain and Spinal Cord Tumors.
Adv Exp Med Biol. 2023 Jan 2, 2023;1394:85-101
. doi: 10.1007/978-3-031-14732-6_6. PMID: 36587383. Review˰

Medikonda R, Pant A, Lim M.
Immunotherapy as a New Therapeutic Approach for Brain and Spinal Cord Tumors.
Adv Exp Med Biol. 2023 Jan 2, 2023;1394:73-84
. doi: 10.1007/978-3-031-14732-6_5. PMID: 36587382. Review˰

Shobeiri P, Seyedmirzaei H, Kalantari A, Mohammadi E, Rezaei N, Hanaei S.
The Epidemiology of Brain and Spinal Cord Tumors.
Adv Exp Med Biol. 2023 Jan 2, 2023;1394:19-39
. doi: 10.1007/978-3-031-14732-6_2. PMID: 36587379. Review˰

Walbert T, Stec NE.
Palliative care in brain tumors.
Handb Clin Neurol. 2023 Jan 2, 2023;191:69-80
. doi: 10.1016/B978-0-12-824535-4.00011-2. PMID: 36599516. Review˰

Yoon WS, Chung DS.
Advanced T and NK Cell Therapy for Glioblastoma.
J Korean Neurosurg Soc. 2023 Jan 2
. doi: 10.3340/jkns.2022.0267. PMID: 36588388. Review.

Khan F, Pang L, Dunterman M, Lesniak MS, Heimberger AB, Chen P.
Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy.
J Clin Invest. 2023 Jan 3, 2023;133(1):e163446
. doi: 10.1172/JCI163446. PMID: 36594466. Review.

Friedmann-Morvinski D, Hambardzumyan D.
Monocyte-neutrophil entanglement in glioblastoma.
J Clin Invest. 2023 Jan 3, 2023;133(1):e163451
. doi: 10.1172/JCI163451. PMID: 36594465. Review.

Li S, Wang C, Chen J, Lan Y, Zhang W, Kang Z, Zheng Y, Zhang R, Yu J, Li W.
Signaling pathways in brain tumors and therapeutic interventions.
Signal Transduct Target Ther. 2023 Jan 4, 2023;8(1):8
. doi: 10.1038/s41392-022-01260-z. PMID: 36596785. Review.

Roux A, Zanello M, Simboli GA, Varlet P, Tauziède-Espariat A, Beccaria K, Blauwblomme T, Puget S, Oppenheim C, Dangouloff-Ros V, Boddaert N, Dhermain F, Dufour C, Grill J, Chrétien F, Pallud J.
Clinico-radio-histo-molecular and neurocognitive characteristics of diffuse gliomas in adolescent and young adults. A comprehensive review.
Oncology. 2023 Jan 5
. doi: 10.1159/000528588. PMID: 36603564. Review˰

Halfpenny AM, Wood M.
Review of the Recent Changes in the WHO Classification for Pediatric Brain and Spinal Cord Tumors.
Pediatr Neurosurg. 2023 Jan 6
. doi: 10.1159/000528957. PMID: 36617415. Review.

Ellingson BM, Wen PY, Chang SM, van den Bent M, Vogelbaum MA, Li G, Li S, Kim J, Youssef G, Wick W, Lassman AB, Gilbert MR, de Groot JF, Weller M, Galanis E, Cloughesy TF.
Objective response rate (ORR) targets for recurrent glioblastoma clinical trials based on the historic association between ORR and median overall survival.
Neuro Oncol. 2023 Jan 7:noad002
. doi: 10.1093/neuonc/noad002. PMID: 36617262. Review.

Horbinski C, Nabors LB, Portnow J, Baehring J, Bhatia A, Bloch O, Brem S, Butowski N, Cannon DM, Chao S, Chheda MG, Fabiano AJ, Forsyth P, Gigilio P, Hattangadi-Gluth J, Holdhoff M, Junck L, Kaley T, Merrell R, Mrugala MM, Nagpal S, Nedzi LA, Nevel K, Nghiemphu PL, Parney I, Patel TR, Peters K, Puduvalli VK, Rockhill J, Rusthoven C, Shonka N, Swinnen LJ, Weiss S, Wen PY, Willmarth NE, Bergman MA, Darlow S.
NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022.
J Natl Compr Canc Netw. 2023 Jan 10, 2023;21(1):12-20
. doi: 10.6004/jnccn.2023.0002. PMID: 36634606. Guidelines.

Oh KS, Mahalingam M.
Melanoma and Glioblastoma-Not a Serendipitous Association.
Adv Anat Pathol. 2023 Jan 10
. doi: 10.1097/PAP.0000000000000393. PMID: 36624550. Review˰

Aseel A, McCarthy P, Mohammed A.
Brain magnetic resonance spectroscopy to differentiate recurrent neoplasm from radiation necrosis: A systematic review and meta-analysis.
J Neuroimaging. 2023 Jan 11
. doi: 10.1111/jon.13080. PMID: 36631883. Review, Meta-analysis˰

Bernstock JD, Blitz S, Kang KD, Friedman GK.
Intraventricular immunovirotherapy; a translational step forward.
Oncotarget. 2023 Jan 12, 2023;14:40-43
. doi: 10.18632/oncotarget.28343. PMID: 36634220. Perspective.

Capper D, Reifenberger G, French PJ, Schweizer L, Weller M, Touat M, Niclou SP, Euskirchen P, Haberler C, Hegi ME, Brandner S, Le Rhun E, Rudà R, Sanson M, Tabatabai G, Sahm F, Wen PY, Wesseling P, Preusser M, van den Bent MJ.
EANO guideline on rational molecular testing of gliomas, glioneuronal and neuronal tumors in adults for targeted therapy selection.
Neuro Oncol. 2023 Jan 12:noad008
. doi: 10.1093/neuonc/noad008. PMID: 36632791. Guidelines.

Johnson KJ, Bauchet L, Francis SS, Hainfellner JA, Kruchko C, Lau CC, Ostrom QT, Scheurer ME, Yuan Y.
Pediatric brain tumors: Origins, epidemiology, and classification - The 2022 Brain Tumor Epidemiology Consortium meeting report.
Clin Neuropathol. 2023 Jan 12
. doi: 10.5414/NP301520. PMID: 36633374. Meeting report˰

Rodriguez-Almaraz JE, Butowski N.
Therapeutic and Supportive Effects of Cannabinoids in Patients with Brain Tumors (CBD Oil and Cannabis).
Curr Treat Options Oncol. 2023 Jan 12
. doi: 10.1007/s11864-022-01047-y. PMID: 36633803. Review.

Kotecha R, Odia Y, Khosla AA, Ahluwalia MS.
Key Clinical Principles in the Management of Glioblastoma.
JCO Oncol Pract. 2023 Jan 13:OP2200476
. doi: 10.1200/OP.22.00476. PMID: 36638331. Review.

Shonka NA, Horbinski CM.
Reconciling the Contemporary Molecular Diagnosis of Glioblastoma With Past Clinical Trial Data.
JCO Oncol Pract. 2023 Jan 13:OP2200784. doi: 10.1200/OP.22.00784. PMID: 36638329. Comment˰
Refers to: Kotecha R, et al., Key Clinical Principles in the Management of Glioblastoma.
JCO Oncol Pract. 2023 Jan 13:OP2200476
. doi: 10.1200/OP.22.00476. PMID: 36638331. Review.